GeoVax Receives Notice Of Allowance For Hepatitis B Vaccine Patent
Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide
Atlanta, GA, April 01, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against …
Read More
0
